Alfredo Aguirre, MD
Rheumatology · Portland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 11 years
- Emory University School of Medicine, 2015
Offices
1 location · University Professional Services · 1,683 clinicians in this group
Hospitals listed: Adventist Health Columbia Gorge · OHSU Hospital and Clinics. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aguirre’s office at (503) 494-8311 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A145432 · Current
Licensed to practise in California · since 2016 · expires 2026-09-30 · Emory University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Rheumatology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mid-Columbia Medical CenterThe Dalles, ORAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 4 of 5 · 57% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- OHSU Hospital and ClinicsPortland, ORAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Oregon Health and Science University, which runs 2 hospitalsHome of Knight Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.31 (1.1 to 1.51), Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 6.83 (5.37 to 8.29) · 3,784 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.733, Oct 2024 – Sep 2025
See every measure and the patient survey for Mid-Columbia Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 2 better, 6 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 140 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.42 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 94 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16 · 59 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 476 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.44) · 1,087 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,058 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.11 (0.62 to 5.61) · 200 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.25 (0.55 to 3.96) · 181 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.12 (0 to 17.6) · 53 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.97 (0.74 to 9.21) · 46 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.43 (0 to 1.54) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.802 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 100 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -27 · 96 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -64.2 · 76 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4 to 9.7) · 59 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (8.1 to 16.3) · 59 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.3 to 18) · 664 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 241 cases | No different | Jan 2024 – Dec 2024 |
What patients said (284 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 57% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for OHSU Hospital and Clinics
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.31 (1.1 to 1.51) | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 6.83 (5.37 to 8.29) · 3,784 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.733 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.38 (0.61 to 2.14) · 2,275 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 150.45 (118.94 to 181.96) · 340 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 98 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 197 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.7 · 145 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 273 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,434 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.07 to 0.43) · 7,501 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.06 to 0.42) · 7,980 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.42 (1.27 to 3.57) · 2,337 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (1.24 to 3.31) · 3,615 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.99 (7.55 to 14.42) · 2,153 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.35 (5.23 to 9.48) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.98 (0.69 to 3.27) · 1,001 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.66 (0.18 to 1.14) · 6,661 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 56 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.838 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.8 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.936 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.381 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.174 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 180 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 320 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 11.9 · 120 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.9 · 223 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.5 · 142 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.6 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.9 to 6.3) · 952 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.5 (8 to 11.4) · 952 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (9.1 to 15.4) · 1,483 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 1,425 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 24% of those asked)
| Cleanliness | 2 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$38,235
Medicare paid this office $38,235 for 180 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 99 | $13,095 | $83 |
| New patient visit (60+ min) | 54 | $10,411 | $193 |
| Return visit (30+ min) | 33 | $4,210 | $117 |
| Long return visit (40+ min) | 19 | $3,265 | $163 |
| New patient visit (45+ min) | 20 | $3,006 | $150 |
See all 7 services
| Short return visit (20+ min) | 99 | $13,095 | $83 |
| New patient visit (60+ min) | 54 | $10,411 | $193 |
| Return visit (30+ min) | 33 | $4,210 | $117 |
| Long return visit (40+ min) | 19 | $3,265 | $163 |
| New patient visit (45+ min) | 20 | $3,006 | $150 |
| New patient visit (30+ min) | 16 | $1,594 | $100 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $38 | None |
Who their Medicare patients are
180 Original Medicare patients in 2024. Average age 75 · Women 68% · Also on Medicaid 16% · Health risk score 1.24. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 66% · Coronary heart disease 27% · Depression 23% · Chronic kidney disease 20% · Atrial fibrillation 17% · Diabetes 16% · Cancer 14% · Heart failure 12% · COPD 11% · Stroke 9%.
The office billed $195,688, Medicare allowed $48,290 and paid $38,235; for 397 services of 16 kinds; $38 of it was for drugs given in the office and $38,198 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 180 | 397 | 75 | 1.24 | $195,688 | $38,235 |
| 2023 | 13 | 14 | 59 | 1.78 | $9,234 | $598 |
| 2022 | 16 | 21 | 57 | 1.77 | $14,842 | $2,286 |
| 2019 | 104 | 106 | 76 | 3.50 | $101,130 | $16,614 |
| 2018 | 97 | 101 | 73 | 3.24 | $101,284 | $17,172 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $12,801 | $173 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,328 | $121 |
2018: 2 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $12,242 | $180 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,330 | $121 |
Medicaid work
$168 in 2024
Medicaid paid $168 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 12 | $168 |
| 2024 | 12 | 1 | 12 | $168 |
| 2019 | 54 | 1 | 22 | $6,420 |
| 2018 | 28 | 2 | 14 | $1,588 |
See the largest Medicaid services in earlier years
2019
| 1ST HOSP IP/OBS HIGH 75 | 54 | $6,420 |
2018
| 1ST HOSP IP/OBS HIGH 75 | 14 | $1,588 |
| Return visit (30+ min) | 14 | $0 |
Drugs they prescribed that Part D paid
$200,052
Pharmacies billed $200,052 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (15 of 562) in 2024. Above the middle of the specialty; the typical rheumatology clinician is at 3%.
532 generic and fewer than 11 brand-name prescriptions · $200,052 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Colchicine | 31 | $3,524 | $114 |
| Febuxostat | 20 | $2,659 | $133 |
| Hydroxychloroquine Sulfate | 68 | $2,370 | $35 |
| Celecoxib | 24 | $933 | $39 |
| Duloxetine | 15 | $844 | $56 |
See all 12 drugs
| Colchicine | 31 | $3,524 | $114 |
| Febuxostat | 20 | $2,659 | $133 |
| Hydroxychloroquine Sulfate | 68 | $2,370 | $35 |
| Celecoxib | 24 | $933 | $39 |
| Duloxetine | 15 | $844 | $56 |
| Prednisone | 131 | $818 | $6 |
| Methotrexate | 26 | $602 | $23 |
| Gabapentin | 33 | $436 | $13 |
| Azathioprine | 14 | $367 | $26 |
| Allopurinol | 43 | $365 | $8 |
| Hydrocodone-Acetaminophen | 13 | $304 | $23 |
| Diclofenac | 11 | $152 | $14 |
Year by year
| 2024 | 562 | 153 | 3% (15) | None | $200,052 |
| 2023 | 102 | 26 | 0% (0) | None | $55,513 |
| 2022 | 193 | 46 | None | None | $388,151 |
| 2021 | 146 | 21 | 0% (0) | 47% | $431,865 |
| 2020 | 140 | 20 | 0% (0) | 46% | $332,194 |
| 2019 | 69 | 23 | 0% (0) | 39% | $107,610 |
| 2018 | 102 | 21 | 0% (0) | None | $4,492 |
| 2017 | 77 | 18 | None | 17% | $4,286 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Mycophenolate Mofetil | 13 | $1,781 | $137 |
| Hydroxychloroquine Sulfate | 19 | $1,323 | $70 |
| Prednisone | 20 | $165 | $8 |
2022: 6 drugs
| Humira(Cf) | 25 | $169,376 | $6,775 |
| Enbrel | 12 | $82,650 | $6,888 |
| Hydroxychloroquine Sulfate | 14 | $992 | $71 |
| Methotrexate | 27 | $692 | $26 |
| Prednisone | 18 | $319 | $18 |
| Diclofenac | 11 | $214 | $19 |
2021: 5 drugs
| Humira(Cf) | 27 | $161,680 | $5,988 |
| Enbrel | 25 | $157,093 | $6,284 |
| Hydroxychloroquine Sulfate | 19 | $2,060 | $108 |
| Methotrexate | 24 | $500 | $21 |
| Allopurinol | 11 | $193 | $18 |
2020: 5 drugs
| Enbrel | 25 | $143,409 | $5,736 |
| Humira | 13 | $76,023 | $5,848 |
| Methotrexate | 24 | $479 | $20 |
| Allopurinol | 11 | $150 | $14 |
| Prednisone | 12 | $84 | $7 |
2019: 1 drug
| Prednisone | 11 | $51 | $5 |
Money from drug and device companies
$18 in 2025
| 2025 | 1 | 1 | None | $18 |
| 2024 | 2 | 3 | None | $46 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $18 | 1 payment
|
See the published payment
| Abbvie | Meals · 2025-01-17 | Rinvoq | $18 |
See earlier years (2024)
2024: $46
| Amgen | Tavneos | $31 | 2 payments
|
| Abbvie | Rinvoq | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1184019267
- Licence
- CA A145432California A145432: Current · expires 2026-09-30
- Trained
- Emory University School of Medicine, 2015 · 11 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
- Mailing address
- 3181 Sw Sam Jackson Park Rd, Portland, OR, 97239
- NPI first listed
- 2015-04-05
- NPI last updated
- 2025-08-27
- NPI record certified
- 2025-08-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 513 Parnassus Ave., San Francisco, CA, 94143 · UCSF, San Francisco, CA, 94143